MT-9938
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MT-9938, covering 2022-02-09 to 2022-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis [Phase 2]